PCI-34051

PCI-34051

Catalog Number:
L002369004APE
Mfr. No.:
APE-A4091
Price:
$202
  • Size:
    Quantity:
    Add to Cart:
      • Overview
        • Please contact us at for specific academic pricing.

          Background

          PCI-34051 is a potent, specific inhibitor of histone deacetylase 8 (HDAC8) with greater than 200-fold selectivity over the other HDAC isoforms, such as 1, 2, 3, 6 and 10. It induces caspase dependent apoptosis in cell lines derived from T-cell lymphomas or leukemias, but not in other hematopoietic or solid tumor lines. PCI-34051 does not cause detectable histone or tubulin acetylation and also does not inhibit growth or induce apoptosis in normal cells such as PBMCs or fibroblasts. Although a phospholipase C-gamma1 (PLCgamma1) defective line is resistant, cells defective in T-cell receptor signaling are still sensitive to PCI-34051 induced apoptosis.

          [1]. S Balasubramanian, J Ramos, W Luo, M Sirisawad, E Verner, J J Buggy. A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas. Leukemia (2008) 22, 1026–1034.
          [2]. Sriram Balasubramanian, Erik Verner, Joseph J. Buggy. Isoform-specific histone deacetylase inhibitors: The next step? Cancer Letters. Volume 280, Issue 2, 8 August 2009, Pages 211–221.

      • Properties
        • Alternative Name
          PCI34051, PCI 34051; N-hydroxy-1-[(4-methoxyphenyl)methyl]indole-6-carboxamide
          CAS Number
          950762-95-5
          Molecular Formula
          C17H16N2O3
          Molecular Weight
          296.32
          Purity
          98.00%
          Solubility
          insoluble in H2O; insoluble in EtOH; ≥14.8 mg/mL in DMSO
          Storage
          Store at -20°C

          * For Research Use Only

      • Reference
        • 1. Yu X, Li H, et al. "Involvement of p53 acetylation in growth suppression of Cutaneous T-cell lymphomas induced by HDAC inhibition." J Invest Dermatol. 2020;S0022-202X(20)30214-1. PMID:32119867
          2. Huang Y, Yang W, et al. "Droxinostat sensitizes human colon cancer cells to apoptotic cell death via induction of oxidative stress." Cell Mol Biol Lett. 2018 Jul 28;23:34. PMID:30065760

    We Also Recommend

    CUDC-101

    $250

    MC1568

    $188

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.